SHANGHAI — Sequanta Technologies Co., Ltd. (“Sequanta”) and Mission Bio. (“Mission Bio”) are pleased to announce that they have entered into a strategic partnership, providing high-quality single-cell sequence services using Mission Bio’s products to customers in mainland China. With this new and important collaboration, customers in China will have access to run Mission Bio fee-for-service projects in a similar […]
About the partnership Brussels, Belgium – Ovizio Imaging Systems, a manufacturer of cell analyzers for advanced monitoring in the bioprocessing market, and BCC, an organization providing training, research services, and design of infrastructures for biopharmaceutical production, today announced that they will enter into a collaboration to broaden the range of monitoring tools for the bioprocessing industry. […]
New media panel, gene kit and advanced resins help reduce manufacturing costs while increasing the viability of gene therapies CARLSBAD, Calif. — For gene therapy developers seeking to rapidly and efficiently scale production, a set of solutions is now available from Thermo Fisher Scientific to support adeno-associated viral (AAV) manufacturing. A new media panel, gene kit and […]
Horizon Discovery is proud to announce that we are collaborating with YCharOS, Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins, as members of YCharOS’s newly formed Industry Advisory Committee (IAC). The role of the IAC is to support YCharOS in realizing its purpose to enable users […]
VectorBuilder – a global leader in vector design, optimization and GMP manufacturing – has formed a worldwide strategic partnership with Univercells Technologies, a provider of novel biomanufacturing technologies for flexible and scalable viral vector production. VectorBuilder’s manufacturing center in Guangzhou, China, will work with Univercells Technologies to develop and optimize platform processes for the production […]
Risk-sharing alliance on tailor-made phenotypic models for IBD and HBV Upfront payment and milestone payments for MIMETAS Access to know-how on novel disease models and assays for Roche Option to exclusively license of disease models and assays for Roche LEIDEN, The Netherlands — MIMETAS, a leader in organ-on-chip-based disease models and technology, and Roche, a world-leading pharmaceutical […]
Göttingen Portfolio expanded by cell culture components, such as growth factors, cytokines, and media CellGenix site in Freiburg to be expanded into a center of excellence for the development and production of cell culture components The life science group Sartorius, through its subgroup Sartorius Stedim Biotech, has acquired a majority stake in the reagent manufacturer […]
Manufacturing partnership enables suspension-based manufacture of gene therapies and viral vector-based vaccines PORT WASHINGTON, N.Y. – Pall Corporation, a global leader in filtration, separation and purification, today announced a new contract worth more than $7M with full-service contract development and manufacturing organization (CDMO) Exothera S.A. The new contract with Pall will establish a suspension-based manufacturing platform […]
AMSBIO have supplied custom lentivectors to Francesco Pampaloni and his team at the Buchmann Institute for Molecular Life Sciences (BMLS) in Frankfurt, Germany allowing them to visualize cell nuclei and F-actin cytoskeleton in their organoids. Organoids are morphologically heterogeneous 3-dimensional cell culture systems that provide an ideal model for understanding the principles of collective cell behavior […]
Life Sciences Veteran to Lead Commercialization of Disruptive Digital PCR Technology for a Broad Range of Basic Research and Clinical Applications BOSTON & PARIS — Stilla Technologies, the company innovating the next generation of digital PCR solutions for life science research and clinical diagnostics, today announced the appointment of Matthew Grow, PhD, to Vice President […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
